Genomma Lab Internacional SAB de CV

Common Name
Genomma Lab Internacional
Country
Mexico
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,708
Ticker
LABB
Exchange
BOLSA MEXICANA DE VALORES
Description
Genomma Lab Internacional S.A.B. de C.V. is a leading consumer healthcare company based in Mexico, known for its extensive portfolio of over-the-counter (OTC) pharmaceuticals and personal care product...

Genomma Lab Internacional's GHG Emissions Data Preview

In 2023, Genomma Lab Internacional completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Genomma Lab Internacional has also provided a category-level breakdown for 7 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
b
0000000
Download Data

Verified Sources Behind Genomma Lab Internacional’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Genomma Lab Internacional’s data sources below and access millions more through our Disclosure Search.

a. Genomma Lab Internacional's Environmental Report 2023
a. Genomma Lab Internacional's Environmental Report 2023
b. Genomma Lab Internacional's Annual Report 2022
b. Genomma Lab Internacional's Annual Report 2022

Insights into Genomma Lab Internacional's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Genomma Lab Internacional amounted to 8,487.96 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Genomma Lab Internacional increased by 25.22%, suggesting that the company faced challenges in reducing its emissions from its core operations. a b

Genomma Lab Internacional's Scope 1 Emissions Over Time

20212022202308001.6 k2.4 k3.2 ktCO2e+61%+16%
  • Total Scope 1
  • Year-over-Year Change

What are Genomma Lab Internacional's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Genomma Lab Internacional were 3,174.3 metric tons of CO₂ equivalent (tCO₂e). a

Has Genomma Lab Internacional reduced its Scope 1 emissions over time?

Since 2021, Genomma Lab Internacional's Scope 1 emissions have increased by 86.18%, reflecting a rising long-term trend in Scope 1 emissions over time. a b

Compared to the previous year (2022), Genomma Lab Internacional's Scope 1 emissions increased by 15.96%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a b

What are Genomma Lab Internacional's Scope 2 emissions?

In 2023, Genomma Lab Internacional reported Scope 2 greenhouse gas (GHG) emissions of 5,313.66 tCO₂e without specifying the calculation method. a

Has Genomma Lab Internacional reduced its Scope 2 emissions over time?

Since 2021, Genomma Lab Internacional's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 78.84%, reflecting a rising long-term trend in Scope 2 emissions over time. a b

Compared to the previous year (2022), Genomma Lab Internacional's Scope 2 emissions (Unspecified Calculation Method) rose by 31.49% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a b

What methodology does Genomma Lab Internacional use for Scope 2 reporting?

In 2023, Genomma Lab Internacional reported its Scope 2 emissions using an unspecified methodology. a

Genomma Lab Internacional's Scope 2 Emissions Over Time

20212022202301.5 k3 k4.5 k6 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Genomma Lab Internacional's Value Chain Emissions

In 2023, Genomma Lab Internacional reported 44,075.12 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2023 disclosure of Genomma Lab Internacional includes a breakdown across 7 of the 15 Scope 3 categories defined by the GHG Protocol, up from 3 in 2022, reflecting improved emissions accounting practices and greater transparency across the company's value chain a

Genomma Lab Internacional's Scope 3 Emissions Over Time

202120222023015 k30 k45 k60 ktCO2e-16%+1%
  • Total Scope 3
  • Year-over-Year Change

What are Genomma Lab Internacional's Scope 3 emissions?

In 2023, Genomma Lab Internacional reported total Scope 3 emissions of 44,075.12 metric tons of CO₂ equivalent (tCO₂e). a

Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment. a

Has Genomma Lab Internacional reduced its Scope 3 emissions over time?

Since 2021, Genomma Lab Internacional's Scope 3 emissions have decreased by 15.3%, reflecting a declining long-term trend in Scope 3 emissions over time. a b

Compared to the previous year (2022), Genomma Lab Internacional's Scope 3 emissions remained relatively stable, indicating that Genomma Lab Internacional 's emissions have plateaued with no significant change in its value chain footprint. a b

What categories of Scope 3 emissions does Genomma Lab Internacional disclose?

In 2023, Genomma Lab Internacional reported emissions for 7 out of the 15 Scope 3 categories defined by the GHG Protocol. a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of Genomma Lab Internacional's Scope 3 emissions?

In 2023, the largest contributors to Genomma Lab Internacional's Scope 3 emissions were: a

  • Purchased Goods and Services (Cat. 1): 34,851.56 tCO₂e (79.07%)
  • Downstream Transportation and Distribution (Cat. 9): 5,622.95 tCO₂e (12.76%)
  • Fuel- and Energy-Related Services (Cat. 3): 1,963.64 tCO₂e (4.46%)

Genomma Lab Internacional's Scope 3 Emissions by Categories

DownstreamTransportation andDistribution(Cat. 9)(12.8%)Fuel- andEnergy-RelatedServices (Cat. 3)(4.5%)Purchased Goods andServices (Cat. 1)(79.1%)

Insights into Genomma Lab Internacional’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Genomma Lab Internacional reported Scope 1 greenhouse gas (GHG) emissions of 3,174.3 tCO₂e and total revenues of USD 971 millions. This translates into an emissions intensity of 3.27 tCO₂e per millions USD. a

Genomma Lab Internacional's Scope 1 Emissions Intensity Compared to Peers

1005005,00050,000500,000Scope 1 Emissions (tCO2e)1002001,0005,00010,000Revenues (Millions of USD)PDNDMega LifesciencesYear: 2023Scope 1: 1,809 tCO2eRevenue: $M 455Scope 1 Intensity: 3.97 tCO2e/$MGrape King BioYear: 2024Scope 1: 6,559 tCO2eRevenue: $M 341Scope 1 Intensity: 19.25 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MHUTCHMED (China)Year: 2024Scope 1: 3,083 tCO2eRevenue: $M 4,926Scope 1 Intensity: 0.63 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MAbbott IndiaYear: 2025Scope 1: 232 tCO2eRevenue: $M 750Scope 1 Intensity: 0.31 tCO2e/$MLaboratorios Farmaceuticos ROVIYear: 2024Scope 1: 9,566 tCO2eRevenue: $M 795Scope 1 Intensity: 12.04 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 398Scope 1 Intensity: 136.27 tCO2e/$MEvotecYear: 2024Scope 1: 13,756 tCO2eRevenue: $M 829Scope 1 Intensity: 16.59 tCO2e/$MJB PharmaYear: 2025Scope 1: 5,652 tCO2eRevenue: $M 452Scope 1 Intensity: 12.50 tCO2e/$MBoironYear: 2024Scope 1: 4,720 tCO2eRevenue: $M 507Scope 1 Intensity: 9.30 tCO2e/$MNatco PharmaYear: 2025Scope 1: 28,495 tCO2eRevenue: $M 518Scope 1 Intensity: 54.96 tCO2e/$MDDDong-E-E-JiaoYear: 2023Scope 1: 15,659 tCO2eRevenue: $M 663Scope 1 Intensity: 23.60 tCO2e/$MStrides Pharma ScienceYear: 2023Scope 1: 6,168 tCO2eRevenue: $M 439Scope 1 Intensity: 14.04 tCO2e/$MNNNippon ShinyakuYear: 2023Scope 1: 4,366 tCO2eRevenue: $M 1,082Scope 1 Intensity: 4.03 tCO2e/$MAlkem LaboratoriesYear: 2025Scope 1: 33,018 tCO2eRevenue: $M 1,499Scope 1 Intensity: 22.03 tCO2e/$MEuroapiYear: 2024Scope 1: 60,846 tCO2eRevenue: $M 957Scope 1 Intensity: 63.61 tCO2e/$MSwedish Orphan BiovitrumYear: 2024Scope 1: 1,097 tCO2eRevenue: $M 2,362Scope 1 Intensity: 0.46 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MLupinYear: 2025Scope 1: 82,174 tCO2eRevenue: $M 2,597Scope 1 Intensity: 31.64 tCO2e/$MDDDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$MAspen Pharmacare HoldingsYear: 2025Scope 1: 32,776 tCO2eRevenue: $M 2,450Scope 1 Intensity: 13.38 tCO2e/$MPiramal PharmaYear: 2025Scope 1: 61,351 tCO2eRevenue: $M 1,061Scope 1 Intensity: 57.85 tCO2e/$MIPCA LaboratoriesYear: 2025Scope 1: 169,992 tCO2eRevenue: $M 1,036Scope 1 Intensity: 164.03 tCO2e/$MGenomma Lab InternacionalYear: 2023Scope 1: 3,174 tCO2eRevenue: $M 971Scope 1 Intensity: 3.27 tCO2e/$M

How does Genomma Lab Internacional's GHG emissions intensity compare to its peers?

In 2023, Genomma Lab Internacional reported a Scope 1 emissions intensity of 3.27 tCO₂e per millions USD. Compared to the peer group median of 19.25 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Genomma Lab Internacional rank on GHG emissions intensity within its industry?

In 2023, Genomma Lab Internacional ranked 4 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Genomma Lab Internacional among the top performers, with one of the lowest emissions intensities relative to peers. a

Insights into Genomma Lab Internacional's Total Carbon Footprint

In 2023, Genomma Lab Internacional reported a total carbon footprint of 52,563.08 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 4.61% increase compared to 2022, suggesting a rise in emissions across its operations or value chain. a b

The largest contributor to Genomma Lab Internacional's total carbon footprint was Scope 3 emissions, accounting for 83.85% of the company's total carbon footprint, followed by Scope 2 emissions at 10.11%. a

Want Full Access to Genomma Lab Internacional's GHG Emissions Dataset?
Sign Up